We are live on ! Find out more
SG

StoneX Group Portfolio holdings

AUM $1.86B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+7.11%
1 Year Est. Return
+21.3%
3 Year Est. Return
+67.54%
5 Year Est. Return
+78.7%
10 Year Est. Return
AUM
$674M
AUM Growth
+$118M
Cap. Flow
+$83.2M
Cap. Flow %
12.33%
Top 10 Hldgs %
25.56%
Holding
498
New
85
Increased
270
Reduced
98
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 7.38%
2 Healthcare 5.2%
3 Consumer Discretionary 3.22%
4 Industrials 3.18%
5 Financials 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLOT icon
451
iShares Floating Rate Bond ETF
FLOT
$10.1B
$201K 0.03%
+3,956
New +$201K
GILD icon
452
Gilead Sciences
GILD
$161B
$201K 0.03%
+2,918
New +$195K
AMC icon
453
AMC Entertainment Holdings
AMC
$2.03B
$200K 0.03%
+353
New +$93.5K
MDYV icon
454
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.76B
$200K 0.03%
+2,968
New +$204K
NBEV
455
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$185K 0.03%
82,750
-157,150
-66% -$366K
AUPH icon
456
Aurinia Pharmaceuticals
AUPH
$1.97B
$138K 0.02%
+10,650
New +$136K
IRIX icon
457
IRIDEX
IRIX
$15.5M
$138K 0.02%
19,575
FXN icon
458
First Trust Energy AlphaDEX Fund
FXN
$398M
$123K 0.02%
10,769
+152
+1% +$1.62K
GNPX icon
459
Genprex
GNPX
$3.94M
$118K 0.02%
1
SAN icon
460
Banco Santander
SAN
$194B
$113K 0.02%
+28,992
New +$112K
BW icon
461
Babcock & Wilcox
BW
$1.43B
$106K 0.02%
13,500
AXDX
462
DELISTED
Accelerate Diagnostics
AXDX
$95K 0.01%
1,174
-40
-3% -$3.18K
BBVA icon
463
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$94K 0.01%
+15,087
New +$89.3K
CANF
464
Can-Fite BioPharma American Depositary Shares
CANF
$6.83M
$91K 0.01%
+200
New +$87.7K
KEEL
465
Keel Infrastructure Corp
KEEL
$2.57B
$81K 0.01%
+20,564
New +$84.2K
BDRX
466
Biodexa Pharmaceuticals
BDRX
$1.49M
0
BRCN
467
DELISTED
Burcon NutraScience Corporation
BRCN
$56K 0.01%
+19,998
New +$63.9K
THER
468
DELISTED
THERATECHNOLOGIES INC COM
THER
$54K 0.01%
14,000
DNN icon
469
Denison Mines
DNN
$2.63B
$30K ﹤0.01%
+25,000
New +$30K
AIXC
470
AIxCrypto Holdings Inc
AIXC
$16.6M
$27K ﹤0.01%
27
ZOM
471
DELISTED
Zomedica Corp.
ZOM
$17K ﹤0.01%
20,000
NEPT
472
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$12K ﹤0.01%
+7
New +$12.7K
ALB icon
473
Albemarle
ALB
$13.5B
-1,613
Closed -$236K
AWAY icon
474
Amplify Travel Tech ETF
AWAY
$24M
-27,948
Closed -$874K
BOND icon
475
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.28B
-1,932
Closed -$211K

Similar funds

StoneX Group's Q2 2021 Portfolio in Review

As of Q2 2021, StoneX Group held 498 positions worth $674M, up 21% from $557M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

StoneX Group deployed $83.2M of net new capital in Q2 2021, opening 85 new positions and adding to 270 existing holdings. Its largest new stake was Smith & Nephew: 268,243 shares worth $11.7M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 7.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $25.3M trimmed.

  • StoneX Group's largest Q2 2021 buy was Smith & Nephew: 268,243 shares worth $11.7M.
  • StoneX Group added most to State Street Industrial Select Sector SPDR ETF in Q2 2021, an estimated $6.64M increase.
  • StoneX Group's biggest Q2 2021 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $25.3M.
  • StoneX Group fully exited Mitsubishi UFJ Financial in Q2 2021, selling an estimated $5.36M.
  • StoneX Group's ten largest holdings make up 26% of its $674M portfolio in Q2 2021.
  • StoneX Group opened 85 new positions and closed 26 in Q2 2021.
  • StoneX Group's portfolio value rose 21% quarter-over-quarter to $674M.

Based on StoneX Group's 13F filing for Q2 2021, filed 6 Aug 2021.